Showing results (71-80 of 215) with videos related to
Sort By:
Pageof 22
Blood Cancer Journal|February 24, 2019
Health-related quality of life in the ENDEAVOR study: carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myelomaHeinz Ludwig, Philippe Moreau, Meletios A Dimopoulos, et al.Haematologica|September 17, 2013
Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapseLudek Pour, Sabina Sevcikova, Henrieta Greslikova, et al.Leukemia & Lymphoma|October 23, 2013
Factors that influence health-related quality of life in newly diagnosed patients with multiple myeloma aged ≥ 65 years treated with melphalan, prednisone and lenalidomide followed by lenalidomide maintenance: results of a randomized trialMeletios A Dimopoulos, Antonio Palumbo, Roman Hajek, et al.Annals of Hematology|November 20, 2009
Salvage treatment with upfront melphalan 100 mg/m(2) and consolidation with novel drugs for fulminant progression of multiple myelomaMarta Krejci, Zdenek Adam, Tomas Buchler, et al.Journal of Clinical Pathology|February 19, 2018
Newly designed 11-gene panel reveals first case of hereditary amyloidosis captured by massive parallel sequencingZuzana Chyra Kufova, Tereza Sevcikova, Jaroslav Januska, et al.Expert Opinion on Investigational Drugs|September 14, 2020
Melflufen for relapsed and refractory multiple myelomaAlbert Oriol, Alessandra Larocca, Xavier Leleu, et al.Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|June 20, 2023
Immunoablative therapy followed by autologous hematopoietic stem cell transplantation as the first-line disease-modifying therapy in patients with multiple sclerosisMartin Lachnit, Kamila Zondra Revendova, Pavel Hradilek, et al.Haematologica|April 27, 2010
Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myelomaHeinz Ludwig, Zdenek Adam, Elena Tóthová, et al.Clinical Lymphoma, Myeloma & Leukemia|August 24, 2011
Association study of selected genetic polymorphisms and occurrence of venous thromboembolism in patients with multiple myeloma who were treated with thalidomideMartina Almasi, Sabina Sevcikova, Ondrej Slaby, et al.Genomics|July 9, 2013
Cell cycle genes co-expression in multiple myeloma and plasma cell leukemiaFedor Kryukov, Elena Dementyeva, Lenka Kubiczkova, et al.Pageof 22